MORGAN GATES: Open Payments
NPI 1174357859 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,149 in 35 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $586 · 2025 $2,149
Food & beverage: $2,149
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $290 |
| Incyte Corporation | 3 | $254 |
| Janssen Biotech, Inc. | 6 | $213 |
| Eisai Inc. | 2 | $145 |
| Novo Nordisk Inc | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $125 |
| Genmab U.S., Inc. | 1 | $125 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Karyopharm Therapeutics Inc. | 1 | $124 |
Products named: RYBREVANT, Lenvima, Jakafi, Wegovy, VENCLEXTA, Zynyz, JOURNAVX, Tivdak.
Industry payments across MO — which companies pay providers there.
